Alpha DNA Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-322
| Closed | -$285K | – | 227 |
|
|
2024
Q3 | $285K | Buy |
+322
| New | +$285K | 0.11% | 186 |
|
|
2023
Q4 | – | Sell |
-5,577
| Closed | -$3M | – | 208 |
|
|
2023
Q3 | $3M | Sell |
5,577
-568
| -9% | -$305K | 1.23% | 7 |
|
|
2023
Q2 | $2.88M | Sell |
6,145
-230
| -4% | -$108K | 0.96% | 8 |
|
|
2023
Q1 | $2.19M | Buy |
6,375
+1,648
| +35% | +$566K | 0.65% | 11 |
|
|
2022
Q4 | $1.73M | Buy |
4,727
+1,103
| +30% | +$404K | 0.61% | 20 |
|
|
2022
Q3 | $1.17M | Buy |
+3,624
| New | +$1.17M | 0.97% | 25 |
|
|
2021
Q2 | – | Sell |
-6
| Closed | -$1K | – | 395 |
|
|
2021
Q1 | $1K | Hold |
6
| – | – | ﹤0.01% | 630 |
|
|
2020
Q4 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 531 |
|